Cargando…
Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
BACKGROUND: MAPT-AS1, a long non-coding RNA, has not been reported in any previous research about its function in cancers. In this study, we investigated the role of MAPT-AS1 in the progression and paclitaxel resistance in breast cancer, and the regulation between MAPT-AS1 and its natural comparable...
Autores principales: | Pan, Yiyuan, Pan, Yiqi, Cheng, Yue, Yang, Fan, Yao, Zhihan, Wang, Ouchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799917/ https://www.ncbi.nlm.nih.gov/pubmed/29441192 http://dx.doi.org/10.1186/s13578-018-0207-5 |
Ejemplares similares
-
Overexpression of lncRNA MAPT-AS1 exacerbates cell proliferation and metastasis in breast cancer
por: Li, Beibei, et al.
Publicado: (2022) -
ZMYND8 suppresses MAPT213 LncRNA transcription to promote neuronal differentiation
por: Adhikary, Santanu, et al.
Publicado: (2022) -
Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
por: Tauber, Christina V., et al.
Publicado: (2023) -
Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014) -
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
por: Park, Susanna B, et al.
Publicado: (2014)